Pharmacists Warn About Nutritional Risks for Patients on Weight Loss Drugs
Pharmacists and health experts are raising concerns about the nutritional risks associated with the use of GLP-1 weight loss drugs, such as Ozempic and Wegovy, which are popular among Americans for treating type 2 diabetes and obesity. These medications work by significantly reducing appetite, which can lead to undernutrition if patients do not carefully manage their diet. Dr. Fatima Cody Stanford from Harvard University highlights the risk of losing lean muscle mass and essential micronutrients like vitamin D, calcium, iron, and B vitamins due to reduced food intake. Additionally, skipping meals or prolonged periods without eating can result in poor dietary balance, fatigue, dizziness, and potential loss of bone density. Experts emphasize the importance of prioritizing protein intake, regular meals, hydration, and resistance training to maintain muscle and metabolic health while using these drugs. 
